Active B12 covered in recent meetings
June and July have been busy months in the 2007 calendar for exhibitions, meetings, workshops and symposia on Active B12. June started with Euromedlab in Amsterdam one of the major clinical chemistry conferences in Europe which is held every 2 years. As well as 3 posters and a symposium from Prof. Ebba Nexo on Active B12 (holotranscobalamin) a successful and well attended workshop, jointly organised by Axis-Shield and Abbott Diagnostics, took place. The workshop was videoed and will be available soon on disk. Following on from this the 6th World Congress in Hyperhomocysteinemia was held in Saarbruecken Germany. Seven posters were presented and well as a scientific workshop. The American Association of Clinical Chemistry (AACC) was held in San Diego in July, 2 posters on Active B12 were presented.
Posters, poster and symposium abstracts from AACC, Euromedlab, and 6th World Congress of Hyperhomocysteinemia are now available to view in the poster section.”
AXIS-SHIELD receives US marketing approval for Active-B12 (HOLOTC) assay on Abbott’s AxSym® analyser
Second assay in project to expand AxSYM's broad test menu now approved by FDA
DUNDEE, Scotland, 30 November 2006 – Axis-Shield (LSE:ASD, OSE:ASD), the international in vitro diagnostics company, today announces that it has received FDA 510(k) marketing approval for its Active-B12 test which runs on Abbott's AxSYM® automated immunoassay system, which is used in thousands of hospitals and clinical laboratories worldwide. The test measures levels of holotranscobalamin (HoloTC), the active, biologically available form of vitamin B12, deficiency of which may be implicated in neurodegenerative conditions such as Alzheimer’s disease and is an increasing problem amongst elderly and vegetarian populations.